| Literature DB >> 16539797 |
Jun Zhu1, James Davis, Deborah A Taira, Marisa Yamashita.
Abstract
INTRODUCTION: Preventive screening is widely recognized as a key component of cost-effective, high-quality health care. Even so, national screening for cancer, diabetes, and cholesterol falls far short of U.S. Preventive Services Task Force recommendations. Although evidence has shown that reminder programs improve preventive screening rates, this study is one of the first to examine the characteristics of health plan members who respond to screening reminders.Entities:
Mesh:
Year: 2006 PMID: 16539797 PMCID: PMC1563981
Source DB: PubMed Journal: Prev Chronic Dis ISSN: 1545-1151 Impact factor: 2.830
Number of Health Plan Members Sent Screening Reminders by Age and Sexa
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| Male | NA | NA | ≥50 (60,616) | ≥45 (36,709) | 35-65 (31,298) |
| Female | 41-90 (42,245) | 18-65 (71,697) | ≥50 (68,398) | ≥45 (46,514) | 45-65 (22,391) |
NA indicates not applicable.
Screening Response Rates to Reminders by Number of Reminders Sent and Type of Screening
|
|
| ||||
|---|---|---|---|---|---|
|
| |||||
|
|
|
|
|
| |
| 1 | 23.9 | 29.6 | 21.5 | 30.8 | 25.3 |
| 2 | 19.1 | 20.0 | 15.8 | 26.4 | 20.4 |
| ≥3 | 12.7 | 13.0 | 13.3 | 23.3 | 18.5 |
FigurePercentage of members responding to screening reminders by calendar month in which reminders were sent.
Screening Rate Ratios by Health Plan Member Characteristics and Type of Screeninga
|
|
| ||||
|---|---|---|---|---|---|
|
| |||||
|
|
|
|
|
| |
|
| |||||
|
| |||||
|
| |||||
| 1 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| 2 | 0.61 (0.58-0.64) | 0.64 (0.62-0.66) | 0.71 (0.69-0.73) | 0.95 (0.93-0.98) | 0.75 (0.72-0.78) |
| ≥3 | 0.37 (0.35-0.40) | 0.38 (0.37-0.40) | 0.52 (0.50-0.54) | 0.79 (0.76-0.83) | 0.62 (0.60-0.65) |
|
| |||||
|
| |||||
|
| |||||
| Male | NA | NA | 1.00 | 1.00 | 1.00 |
| Female | NA | NA | 1.09 (1.07-1.12) | 0.97 (0.94-0.99) | 1.04 (1.00-1.07) |
|
| |||||
|
| |||||
|
| |||||
| ≤20 | NA | 1.00 | NA | NA | NA |
| 21-30 | NA | 1.96 (1.86-2.06) | NA | NA | NA |
| 31-40 | NA | 1.63 (1.55-1.71) | NA | NA | 1.00 |
| 41-50 | 1.00 | 1.39 (1.33-1.46) | 1.00 | 1.00 | 1.43 (1.37-1.49) |
| 51-60 | 1.15 (1.08-1.22) | 1.04 (0.99-1.10) | 1.13 (1.08-1.17) | 1.22 (1.19-1.25) | 1.83 (1.75-1.92) |
| 61-70 | 1.01 (0.95-1.08) | 0.75 (0.70-0.80) | 1.16 (1.11-1.20) | 1.14 (1.10-1.18) | 1.95 (1.82-2.08) |
| 71-80 | 0.47 (0.42-0.52) | NA | 1.10 (1.04-1.15) | 0.80 (0.76-0.84) | NA |
| 81-90 | 0.21 (0.18-0.24) | NA | 0.79 (0.74-0.83) | 0.66 (0.61-0.72) | NA |
| ≥91 | NA | NA | 0.48 (0.42-0.55) | 0.63 (0.51-0.79) | NA |
|
| |||||
|
| |||||
|
| |||||
| 0 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| 1 | 1.40 (1.28-1.52) | 1.36 (1.30-1.42) | 1.41 (1.33-1.49) | 1.16 (1.11-1.21) | 1.26 (1.20-1.32) |
| 2 | 1.57 (1.44-1.70) | 1.53 (1.46-1.61) | 1.63 (1.54-1.72) | 1.39 (1.33- 1.45) | 1.60 (1.52-1.69) |
| 3 | 1.80 (1.65-1.97) | 1.74 (1.65-1.84) | 1.80 (1.70-1.91) | 1.63 (1.55- 1.71) | 2.06 (1.94- 2.19) |
| 4 | 1.74 (1.57-1.92) | 1.76 (1.64-1.88) | 1.75 (1.64-1.86) | 1.68 (1.58- 1.78) | 1.98 (1.82- 2.16) |
| 5 | 1.62 (1.45-1.82) | 1.66 (1.52-1.81) | 1.70 (1.59-1.81) | 1.75 (1.62-1.88) | 2.38 (2.13-2.66) |
|
| |||||
|
| |||||
|
| |||||
| Fee for service | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Health maintenance organization | 1.48 (1.43-1.54) | 1.53 (1.49-1.57) | 1.47 (1.44-1.51) | 1.27 (1.24-1.30) | 1.58 (1.53-1.63) |
| Medicare | 1.21 (1.13-1.30) | 1.21 (1.00-1.48) | 1.54 (1.49-1.59) | 1.63 (1.44-1.86) | 1.86 (1.31-2.64) |
Analyses were adjusted for the island of residence in Hawaii and for the characteristics listed in Table 4.
CI indicates confidence interval; NA, not applicable.
Adjusted Clinical Group (ACG) morbidity levels were determined by Johns Hopkins University School of Hygiene and Public Health (2). The ACG morbidity levels measure the level of overall illness experienced on a scale of 0 to 5, with 5 indicating the most ill.
Screening Rate Ratios by Medical History and Type of Screeninga
|
|
| ||||
|---|---|---|---|---|---|
|
| |||||
|
|
|
|
|
| |
|
| |||||
|
| |||||
|
| |||||
| 0 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| 1 | 1.08 (1.01-1.14) | 1.03 (0.99-1.07) | 1.07 (1.03-1.10) | 1.25 (1.20-1.29) | 1.01 (0.92-1.12) |
| 2-5 | 1.04 (0.99-1.09) | 1.02 (0.98-1.06) | 1.09 (1.06-1.13) | 1.41 (1.37-1.46) | 0.97 (0.89-1.05) |
| 6-10 | 1.01 (0.94-1.07) | 0.99 (0.94-1.04) | 1.16 (1.12-1.21) | 1.64 (1.57-1.71) | 1.05 (0.91-1.21) |
| 11-25 | 1.08 (1.00-1.16) | 1.05 (0.98-1.12) | 1.19 (1.14-1.24) | 1.84 (1.74-1.95) | 1.22 (0.97-1.53) |
| ≥26 | 0.97 (0.83-1.13) | 1.06 (0.91-1.23) | 1.27 (1.16-1.39) | 2.08 (1.78-2.42) | 1.35 (0.78-2.34) |
|
| |||||
|
| |||||
|
| |||||
| 0 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| ≥1 | 0.89 (0.83-0.95) | 0.94 (0.90-0.98) | 0.89 (0.86-0.93) | 0.97 (0.92-1.02) | 1.01 (0.84-1.20) |
|
| |||||
|
| |||||
|
| |||||
| 0 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| ≥1 | 0.82 (0.75-0.90) | 0.97 (0.91-1.04) | 0.85 (0.81-0.90) | 1.00 (0.93-1.07) | 0.67 (0.49-0.90) |
|
| |||||
|
| |||||
|
| |||||
| Primary care | 1.06 (1.01-1.11) | 0.91 (0.88-0.95) | 1.17 (1.14-1.20) | 1.06 (1.03-1.09) | 1.04 (1.00-1.09) |
| Endocrinology | 1.07 (0.97-1.18) | 0.96 (0.88-1.05) | 1.17 (1.11-1.24) | 1.04 (0.95-1.13) | 1.22 (1.06-1.41) |
| Cardiology | 1.01 (0.95-1.08) | 0.88 (0.82-0.95) | 1.02 (0.99-1.06) | 1.02 (0.96-1.07) | 1.13 (1.02-1.24) |
| Obstetrics/gynecology | 1.99 (1.90-2.08) | 1.84 (1.76-1.91) | 1.58 (1.54-1.63) | 0.99 (0.96-1.02) | 0.98 (0.93-1.03) |
| Other | 1.10 (1.05-1.15) | 1.06 (1.02-1.09) | 1.20 (1.17-1.22) | 0.91 (0.88-0.94) | 0.93 (0.89-0.97) |
Analyses were adjusted for the island of residence in Hawaii and for the characteristics listed in Table 3
CI indicates confidence interval.
Data are from the year before health plan members received screening reminders.
Screening Rate Ratios by Multiple Reminders for Overdue Health Screenings Sent to Health Plan Members and by Type of Screeninga
|
|
| ||||
|---|---|---|---|---|---|
|
| |||||
|
|
|
|
|
| |
| Breast cancer | — | 0.22 (0.20-0.23) | 0.46 (0.44-0.48) | 0.80 (0.76-0.83) | 0.85 (0.79-0.91) |
| Cervical cancer | 0.38 (0.37-0.40) | — | 0.54 (0.51-0.57) | 1.09 (1.05-1.13) | 0.97 (0.91-1.02) |
| Colon cancer | 0.49 (0.47-0.51) | 0.55 (0.52-0.58) | — | 0.88 (0.86-0.90) | 1.06 (1.02-1.10) |
| Diabetes | 0.88 (0.83-0.93) | 0.76 (0.71-0.81) | 0.59 (0.57-0.61) | — | 0.23 (0.22-0.25) |
| Cholesterol | 0.97 (0.90-1.05) | 0.95 (0.88-1.02) | 0.58 (0.55-0.62) | 0.19 (0.18-0.20) | — |
Multiple reminders refer to reminders for recommended screenings in addition to the listed screening category (i.e., members receiving a reminder for cervical cancer screening when the analysis outcome is breast cancer screening). Rate ratios measure the screening rates for members who received more than one reminder compared with those who did not. Analyses were adjusted for the island of residence in Hawaii and for the characteristics listed in Tables 3 and 4.
CI indicates confidence interval.
Screening Rate Ratios by Multiple Screenings Received and Type of Screeninga
|
|
| ||||
|---|---|---|---|---|---|
|
| |||||
|
|
|
|
|
| |
| Breast cancer | — | 10.3 (9.6-11.0) | 3.65 (3.44-3.87) | 1.32 (1.24-1.40) | 1.34 (1.23-1.45) |
| Cervical cancer | 7.89 (7.43-8.37) | — | 4.62 (4.31-4.96) | 1.08 (1.02-1.14) | 1.31 (1.22-1.40) |
| Colon cancer | 2.91 (2.76-3.06) | 3.66 (3.44-3.89) | — | 1.81 (1.75-1.87) | 1.47 (1.40-1.54) |
| Diabetes | 1.57 (1.45-1.69) | 1.50 (1.39-1.62) | 2.53 (2.41-2.65) | — | 23.9 (22.8-25.1) |
| Cholesterol | 1.37 (1.25-1.51) | 1.60 (1.46-1.74) | 2.06 (1.92-2.21) | 19.6 (18.7-20.4) | — |
Multiple screenings refer to screenings other than the listed screening category (i.e., members having received screening for cervical cancer when the analysis outcome is breast cancer screening). Rate ratios measure the screening rates for members who received more than one screening compared with those who did not. Analyses were adjusted for the island of residence in Hawaii and for the characteristics listed in Tables 3 and 4.
CI indicates confidence interval.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| Jan | 21.9 | 26.3 | 19.2 | 30.4 | 24.7 |
| Feb | 19.8 | 26 | 16.7 | 28.3 | 22.8 |
| Mar | 21.6 | 25.3 | 19.3 | 29.6 | 22.7 |
| Apr | 21.7 | 25.5 | 19.5 | 29.8 | 23.1 |
| May | 20.8 | 23.9 | 18.5 | 30.7 | 23.8 |
| Jun | 22.9 | 28.2 | 19.5 | 30.8 | 26.7 |
| Jul | 21.2 | 24 | 19.4 | 29.5 | 22.3 |
| Aug | 21.4 | 23.5 | 17.9 | 28.6 | 22.1 |
| Sep | 21.3 | 22.6 | 18.3 | 28 | 22.7 |
| Oct | 20.5 | 23.1 | 17.6 | 27.9 | 22.7 |
| Nov | 19.2 | 21.8 | 16.2 | 26.1 | 20.5 |
| Dec | 18.8 | 20 | 15.2 | 24.7 | 19 |